Al-Sum Hythem A, Alsurori Suhad M, Alkhlassi Maha N, Alanazi Albandari A, Alkhlassi Ibtisam N, Alkhlassi Salma N
Department of Obstetrics and Gynaecology, Division of Maternal Fetal Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, SAU.
College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, SAU.
Cureus. 2023 Nov 21;15(11):e49189. doi: 10.7759/cureus.49189. eCollection 2023 Nov.
Autoimmune hepatitis (AIH) is a rare autoimmune liver disease that mostly affects women in their reproductive years, leading to impaired fertility. Nonetheless, the majority of women with well-controlled AIH have a favorable prognosis for pregnancy. This case report describes a 29-year-old pregnant woman with cirrhosis secondary to AIH who presented with severe thrombocytopenia. Her labs showed a decline in her platelet counts from 28 × 10/L before pregnancy to 20 × 10/L during pregnancy. Her abdominal ultrasound showed liver cirrhosis secondary to AIH and splenomegaly. Throughout pregnancy, various scans were performed to monitor the fetal well-being, which showed normal results. She was on a medication regimen that included nadolol of 80 mg/kg/day, prednisolone of 5 mg/kg/day, and azathioprine of 50 mg/kg/day. Due to a breech presentation, the patient was scheduled for a cesarean section. She received two courses of dexamethasone at 20 mg/day for four days within two weeks of delivery. On the day of her scheduled C-section, tranexamic acid of 1 g TID for two days was administered, and she received platelet transfusions of 12 units both before and after the procedure, with an additional 6 units administered during the procedure. Despite proper management, her platelet count remained consistently low. However, she successfully delivered a healthy baby, and the overall condition of the patient was stable.
自身免疫性肝炎(AIH)是一种罕见的自身免疫性肝病,主要影响育龄女性,导致生育能力受损。尽管如此,大多数AIH病情得到良好控制的女性妊娠预后良好。本病例报告描述了一名29岁的妊娠女性,患有继发于AIH的肝硬化,伴有严重血小板减少症。她的实验室检查显示血小板计数从妊娠前的28×10⁹/L降至妊娠期间的20×10⁹/L。她的腹部超声显示继发于AIH的肝硬化和脾肿大。在整个妊娠期间,进行了各种扫描以监测胎儿健康状况,结果显示正常。她正在接受药物治疗,包括每天80mg/kg的纳多洛尔、每天5mg/kg的泼尼松龙和每天50mg/kg的硫唑嘌呤。由于臀位,患者计划进行剖宫产。在分娩前两周内,她接受了两个疗程的地塞米松治疗,每天20mg,共四天。在预定剖宫产的当天,给予氨甲环酸1g,每日三次,共两天,并在手术前后各输注12单位血小板,手术期间额外输注了6单位。尽管进行了妥善管理,她的血小板计数仍持续偏低。然而,她成功产下了一个健康的婴儿,患者的总体状况稳定。